Inflammatory and autoimmune predictive markers of response to anti‑PD‑1/PD‑L1 therapy in NSCLC and melanoma-Reference-Cited by-同舟云学术

Inflammatory and autoimmune predictive markers of response to anti‑PD‑1/PD‑L1 therapy in NSCLC and melanoma

Published:2022-07-05 Issue:3 Volume:24 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Musaelyan Aram¹,Lapin Sergey¹,Urtenova Margarita²,Odintsova Svetlana²,Chistyakov Ivan³,Ulitin Andrey²,Akopov Andrey³,Orlov Sergey²

Affiliation:

1. Laboratory for Diagnostics of Autoimmune Diseases, Center for Molecular Medicine, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia

2. Department of Clinical Oncology, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia

3. Department of Thoracic Surgery, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference30 articles.

1. Emerging blood-based biomarkers for predicting response to checkpoint immunotherapy in non-small-cell lung cancer;Li;Front Immunol,2020

2. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

3. Blood immune cell biomarkers in patient with lung cancer undergoing treatment with checkpoint blockade;Möller;J Immunother,2020

4. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

5. The role of PD-L1 expression as a predictive biomarker: An analysis of all US food and drug administration (FDA) approvals of immune checkpoint inhibi;Davis;J Immunother Cancer,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of hematological status of cows of different breeds of Western Siberia;Bulletin of NSAU (Novosibirsk State Agrarian University);2024-07-10

2. Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors;Expert Review of Anticancer Therapy;2024-04-17

3. Immune, metabolic landscapes of prognostic signatures for lung adenocarcinoma based on a novel deep learning framework;Scientific Reports;2024-01-04

4. Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance;Journal of Mass Spectrometry and Advances in the Clinical Lab;2023-11

5. Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis;Frontiers in Oncology;2023-10-26